Themis Medicare Ltd. NSE: THEMISMED | BSE: 530199

Expensive Underperformer

Download real time

101.77 1.17 (1.16%)

Near 52W Low of ₹98.00

70,174

NSE+BSE Volume

NSE 11 Sep, 2025 3:31 PM (IST)

Themis Medicare Ltd. News and Updates

Keep track of all breaking news on Themis Medicare Ltd. from all sources in a single place.

Load latest

Themis Medicare Ltd.

13 Jul 2018

101.77

1.16%

FDA order may sink Themis Medicare

Business Line

Themis Medicare, maker of diclofenac 1 ml injection, has been directed by the Food and Drug Administration authorities to stop manufacturing a key pro

Themis Medicare Ltd. has lost -59.25% in the last 1 Year

Themis Medicare Ltd.

18 Apr 2017

101.77

1.16%

Business Line

The board of directors of Themis Medicare has informed the exchanges of the incorporation of a joint venture company Carpo Medical Ltd in the United Kingdom as a private limited company. Themis...

Themis Medicare Ltd. is trading below all available SMAs

Themis Medicare Ltd.

17 Sep 2016

101.77

1.16%

Themis Medicare joins hand with Nevakar to tap US pharma market

Business Standard

As per the deal, Themis will develop a selected number of injectable products that will be manufactured and commercialised by Nevakar in the US and select global markets

Themis Medicare Ltd. is trading below all available SMAs

Themis Medicare Ltd.

08 Jun 2016

101.77

1.16%

Themis Medicare zooms 20% ahead of EGM

Business Standard

The stock rallied 20% at Rs 577 on the BSE on back of heavy volumes.

Themis Medicare Ltd. has lost -29.30% in the last 3 Months

Themis Medicare Ltd.

19 May 2016

101.77

1.16%

Indian pharma Co. may sue drug controller over safety of Novartis painkiller

Economic Times

Novartis' Voveran 1ml and Themis' Aquadol have competed with Troikaa's own injection to manage pain, Dynapar AQ, since their launch in 2013.

Themis Medicare Ltd. is trading below all available SMAs

Indian pharma Co. may sue drug controller over safety of Novartis painkiller

Economic Times | 19 May 2016

Themis Medicare Ltd.

16 May 2016

101.77

1.16%

Themis Medicare rallies on board nod for raising funds

Business Standard

The stock rallied 12% to Rs 507 after the board approved to issue 500,000 shares at Rs 500 per share to non-promoters investors.

Themis Medicare Ltd. has lost -34.78% in the last 6 Months

Themis Medicare Ltd.

20 Jan 2016

101.77

1.16%

Themis Bioscience appoint Dr Philippe Dro and Dr Christian Mandl

The Financial Express

The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine

Themis Medicare Ltd. has lost -34.78% in the last 6 Months

Themis Medicare Ltd.

16 Nov 2015

101.77

1.16%

Themis Medicare hits record high on strong Q2 results

Business Standard

Post Q2 results, the stock zoomed 40% from Rs 268 to Rs 376 compared to 3% decline in S&P BSE Sensex.

Themis Medicare Ltd. is trading below all available SMAs

Is Themis Medicare Ltd. worth buying?

47 Votes:

Buy 80.85%

Sell 10.64%

Hold 8.51%